PolymarketBeschikbaarheid controlerenGeen KYC2% kostenGeverifieerde afwikkelingsgegevensGoed gekalibreerdHuidige impliciete kans
Nee 94.1%
Marktkwaliteit
67 / 100
Gemiddelde kwaliteit24u volume
€ 14,5
Liquiditeit
€ 32,2K
Hoge liquiditeitBied / Laat
5.0% / 6.0%
Spread
1.0 pt
Strakke spreadReacties
7
Marktdata
Bijgewerkt 7 minuten geleden
4 mei 26, 14:41 UTC1 jan 27, 04:59 UTC
Trends
Gerelateerde Markten
Gerelateerde vragen voor context, geen vergelijking van gelijkwaardige contracten.
Will a Hantavirus Vaccine be created in 2026? [Polymarket]
Manifold MarketsHantavirus pandemic in 2026?
PolymarketWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiHantavirus pandemic in 2026?
Manifold MarketsHantavirus pandemic in 2026? [Polymarket]
Manifold MarketsWill the CDC weaken vaccine recommendation against _____ for children and adolescents in 2026?
FutuurRegels
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET.
- Otherwise, this market will resolve to "No".
- The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.
Open markten
Health & MedicinePOLYMARKETHantavirus pandemic in 2026?
- No-0.2pt97%
- Yes+0.2pt3%
- Totaal volume
- € 15,6 mln.
- 24u volume
- € 30,4K
POLYMARKETEbola pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Totaal volume
- € 652,8K
- 24u volume
- € 3,5K
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes-0.7pt3%
- Totaal volume
- € 1,6 mln.
- 24u volume
- € 2,9K
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000+1.0pt97%
- Above 600059%
+2 extra uitkomsten
- Totaal volume
- € 865,3K
- 24u volume
- € 2,7K
POLYMARKETNew pandemic in 2026?
- No+1.0pt94.1%
- Yes-1.0pt5.9%
- Totaal volume
- € 915,3K
- 24u volume
- € 1,4K
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+1.0pt65%
- September41%
- June28%
- Totaal volume
- € 84K
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Will 3 mg THC beverages be federally legal to sell?
- Cyclosporiasis cases reported in the US in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve CagriSema?
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)
- FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)
Veelgestelde vragen
- Wat zijn de huidige kansen voor Hantavirus vaccine in 2026??
- Polymarket prijst No op 94% per 9 september 2026.
- Wanneer wordt Hantavirus vaccine in 2026? afgewikkeld?
- Hantavirus vaccine in 2026? wordt naar verwachting op 1 januari 2027 afgewikkeld.
- Hoe wordt Hantavirus vaccine in 2026? afgewikkeld?
- Polymarket wikkelt deze markt als volgt af: This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET.